Spotlight influenza: Influenza surveillance before and after the introduction of point-of-care testing in Denmark, season 2014/15 to 2018/19
Guido Benedetti(Statens Serum Institut), Hanne‐Dorthe Emborg(Statens Serum Institut), Ramona Trebbien(Ministry of External Affairs), Marianne Voldstedlund(Statens Serum Institut), Tyra Grove Krause(Statens Serum Institut), Didi Bang(Statens Serum Institut), Uffe Vest Schneider(Statens Serum Institut), Jan Gorm Lisby(Amager Hospital)
Cited by 7
Related Papers
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study
|The Lancet Infectious Diseases|2022|218